Researchers compared the rate at which patients diagnosed with both depression and a substance use disorder received acute and continuous pharmacotherapy and psychotherapy with the rate at which patients solely diagnosed with depression received the same treatments.
Clinicians should consider a holistic approach that focuses on how acne effects quality of life (QoL), relationships, and self-image.
Real-world collaborative care programs for depression show large variation in clinical outcomes.
Researchers examined the prevalence of depression symptoms compared to clinically diagnosed depression, as well as the association of depression with mortality in patients with rheumatoid arthritis.
Researchers conducted 1-month follow-ups with patients who had either been treated at the hospital or at home for COVID-19 and found that longer hospital stays were associated with lower scores on psychopathology dimension tests.
Right now, the wellbeing among high-risk groups during the COVID-19 pandemic is an immediate research priority.
Adults with psychosocial and health-related risk factors have an increased risk for experiencing moderate or severe depressive symptoms during the COVID-19 pandemic.
Investigating whether serial ketamine treatments change functional connectivity between limbic structures and resting-state networks.
Research conducted by the CDC concludes that the majority of adolescents, especially those aged 12 to 14 years, are not receiving comprehensive health care transition planning by their primary care provider.
Among individuals with treatment-resistant depression (TRD), the dissociative side effect of “floating” is not related to an antidepressant response to ketamine and thus cannot be utilized as a predictor of treatment response.
